Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1283-1288

  Liss, Michael A ^a,c   Chang, Alexandra ^a   Santos, Rosanne ^a   Nakama Peeples, Amy ^b   Peterson, Ellena M ^b   Osann, Kathryn ^a   Billimek, John ^a   Szabo, Richard J ^d   Dash, Atreya ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

biopsy; drug resistance, microbial; fluoroquinolones; postoperative complications; prostate

Indexed keywords

AMIKACIN; AMPICILLIN; BISACODYL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; ETHNICITY; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; QUESTIONNAIRE; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; BIOPSY, NEEDLE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PROSTATE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79952706824     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.11.088     Document Type: Article

References (20)

1. Hodge KK, McNeal JE and Stamey TA: Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989; 142: 66.
2. Tal R, Livne PM, Lask DM et al: Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 2003; 169: 1762.
3. Patel U and Kirby R: Infections after prostate biopsy and antibiotic resistance. BJU Int 2008; 101: 1201.
4. Sieber PR, Rommel FM, Agusta VE et al: Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997; 157: 2199.
5. Kapoor DA, Klimberg IW, Malek GH et al: Singledose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52: 552.
6. Feliciano J, Teper E, Ferrandino M et al: The incidence of fluoroquinolone resistant infections after prostate biopsy - are fluoroquinolones still effective prophylaxis? J Urol 2008; 179: 952.
7. Young JL, Liss MA and Szabo RJ: Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 2009; 74: 332.
8. Lange D, Zappavigna C, Hamidizadeh R et al: Bacterial sepsis after prostate biopsy-a new perspective. Urology 2009; 74: 1200.
9. Ozden E, Bostanci Y, Yakupoglu KY et al: Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 2009; 74: 119.
10. Shigehara K, Miyagi T, Nakashima T et al: Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008; 14: 40.
11. Nam RK, Saskin R, Lee Y et al: Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963.
12. Horcajada JP, Busto M, Grau S et al: High prevalence of extended-spectrum beta-lactamaseproducing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. Urology 2009; 74: 1195.
13. Jemal A, Siegel R, Ward E et al: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225.
14. Wolf JS Jr, Bennett CJ, Dmochowski RR et al: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008; 179: 1379.
15. Batura D, Rao GG and Nielsen PB: Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010; 106: 1017.
16. Hsu LY, Tan TY, Tam VH et al: Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010; 54: 1173.
17. Lin CY, Huang SH, Chen TC et al: Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. J Microbiol Immunol Infect 2008; 41: 325.
18. Le TM, Baker S, Le TP et al: High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol 2009; 58: 1585.
19. Lee K, Kim YA, Park YJ et al: Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002. Yonsei Med J 2004; 45: 598.
20. Han XY and Andrade RA: Brevundimonas diminuta infections and its resistance to fluoroquinolones. J Antimicrob Chemother 2005; 55: 853.